View Cart (0 items)

Pharmaceutical

Xcelience, Penn Pharma Form Joint Venture

July 12, 2010
Xcelience LLc will expand its pharmaceutical manufacturing to Europe as part of a joint venture agreement with Penn Pharma, reports Bizjournal.com. The joint venture provides pharmaceutical and biotechnology companies a
Read More

Watson Completes Acquisition of Columbia Drug

July 6, 2010
Watson Pharmaceuticals Inc. completed its acquisition of the U.S. rights to a Columbia Laboratories'' progesterone drug in a deal that could be worth more than $92.5 million reports the Associated
Read More

Cannabis-Derived Drug Launches in UK

June 21, 2010
A drug manufactured from cannabis went on sale in the U.K. as a treatment for symptoms of multiple sclerosis. Sativex, which is made from cannabis plants grown at secret
Read More

Novavax Joint Venture Builds Vaccine Factory

June 14, 2010
According to the Associated Press, drug developer Novavax Inc. said its joint venture with an Indian company has finished building a factory in Dholka, India, that will produce flu vaccines.
Read More

Experts Ask Bristol-Myers not to Close French Plant

June 7, 2010
The Associated Press reports officials have urged Bristol-Myers Squibb not to shut down a plant in France, which makes AIDS drugs, saying the move will jeopardize the lives of thousands
Read More

Global Chemical Company will Build State-of-the-Art Facility for European Customers

June 7, 2010
According to PRNewswire, Albemarle Corporation, a global supplier of fine chemistry services for pharmaceutical, agricultural and specialty chemical products, announced it is building a state of the art kilo lab
Read More

Abbott Buys India Unit for $3.7 Billion

May 24, 2010
Abbott Laboratories has agreed to buy the domestic healthcare business of India''s Piramal Healthcare Ltd., a leading branded generics company, for $3.72 billion, the companies announced last week reports
Read More

Japan''s Astellas to Buy US OSI for $4 Billion

May 17, 2010
The Associated Press reports Japanese drug maker, Astellas Pharma Inc., said it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to
Read More

Pfizer Gets Rights to Ergonex Hypertension Drug

May 13, 2010
The Associated Press reports Pfizer Inc. said it acquired the rights to an experimental pulmonary arterial hypertension drug from Swiss drugmaker Ergonex Pharma GmbH. The companies did not disclose terms
Read More

Nigerians Reject Pfizer Payout Over Drug Trial

May 13, 2010
The Associated Foreign Press reports Nigerian families have refused 35 million dollars in compensation from U.S.-based Pfizer over a drug trial blamed for children''s deaths due to a DNA testing
Read More